These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20557999)

  • 1. Gender differences in pain modulation by diffuse noxious inhibitory controls: a systematic review.
    Popescu A; LeResche L; Truelove EL; Drangsholt MT
    Pain; 2010 Aug; 150(2):309-318. PubMed ID: 20557999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of diffuse noxious inhibitory controls in men and women.
    France CR; Suchowiecki S
    Pain; 1999 May; 81(1-2):77-84. PubMed ID: 10353495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of DNIC-type inhibition on temporal summation compared to single pulse processing: does sex matter?
    Lautenbacher S; Kunz M; Burkhardt S
    Pain; 2008 Dec; 140(3):429-435. PubMed ID: 18950941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls (DNIC).
    Baad-Hansen L; Poulsen HF; Jensen HM; Svensson P
    Pain; 2005 Aug; 116(3):359-365. PubMed ID: 15979791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental muscle pain impairs descending inhibition.
    Arendt-Nielsen L; Sluka KA; Nie HL
    Pain; 2008 Dec; 140(3):465-471. PubMed ID: 18977598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of temporal summation and diffuse noxious inhibitory control.
    Cathcart S; Winefield AH; Rolan P; Lushington K
    Pain Res Manag; 2009; 14(6):433-8. PubMed ID: 20011713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of diffuse noxious inhibitory controls (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia.
    Johannesson U; de Boussard CN; Brodda Jansen G; Bohm-Starke N
    Pain; 2007 Jul; 130(1-2):31-9. PubMed ID: 17169489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients.
    Staud R; Robinson ME; Vierck CJ; Price DD
    Pain; 2003 Jan; 101(1-2):167-74. PubMed ID: 12507711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pain contra pain : the concept of DNIC].
    Sprenger C; May A; Büchel C
    Schmerz; 2010 Dec; 24(6):569-74. PubMed ID: 21052732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes.
    van Wijk G; Veldhuijzen DS
    J Pain; 2010 May; 11(5):408-19. PubMed ID: 20075013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.
    Kunz M; Scholl KE; Schu U; Lautenbacher S
    Exp Brain Res; 2006 Nov; 175(2):363-71. PubMed ID: 16816943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of motor cortex modulation and descending inhibitory systems on pain thresholds in healthy subjects.
    Reidler JS; Mendonca ME; Santana MB; Wang X; Lenkinski R; Motta AF; Marchand S; Latif L; Fregni F
    J Pain; 2012 May; 13(5):450-8. PubMed ID: 22515945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization.
    Potvin S; Stip E; Tempier A; Pampoulova T; Bentaleb LA; Lalonde P; Lipp O; Goffaux P; Marchand S
    J Psychiatr Res; 2008 Oct; 42(12):1010-6. PubMed ID: 18093615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in temporal characteristics of descending inhibitory control: an evaluation using repeated bilateral experimental induction of muscle pain.
    Ge HY; Madeleine P; Arendt-Nielsen L
    Pain; 2004 Jul; 110(1-2):72-8. PubMed ID: 15275754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal spinal cord pain processing in Huntington's disease. The role of the diffuse noxious inhibitory control.
    Perrotta A; Serpino C; Cormio C; Serrao M; Sandrini G; Pierelli F; de Tommaso M
    Clin Neurophysiol; 2012 Aug; 123(8):1624-30. PubMed ID: 22341978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleus raphe magnus OFF-cells are involved in diffuse noxious inhibitory controls.
    Chebbi R; Boyer N; Monconduit L; Artola A; Luccarini P; Dallel R
    Exp Neurol; 2014 Jun; 256():39-45. PubMed ID: 24681000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting - and relationships between-different modes of endogenous pain modulation in healthy volunteers.
    Treister R; Eisenberg E; Gershon E; Haddad M; Pud D
    Eur J Pain; 2010 Jul; 14(6):608-14. PubMed ID: 19906552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse noxious inhibitory control function in women with provoked vestibulodynia.
    Sutton KS; Pukall CF; Chamberlain S
    Clin J Pain; 2012 Oct; 28(8):667-74. PubMed ID: 22209799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls.
    Villanueva L; Le Bars D
    Biol Res; 1995; 28(1):113-25. PubMed ID: 8728826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences.
    Goodin BR; McGuire L; Allshouse M; Stapleton L; Haythornthwaite JA; Burns N; Mayes LA; Edwards RR
    J Pain; 2009 Feb; 10(2):180-90. PubMed ID: 19010738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.